Enhanced Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by a Hybrid Hydroxylapatite/Collagen Scaffold.

bone expression gene osteogenesis scaffold

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2020
Historique:
received: 26 09 2020
accepted: 02 12 2020
entrez: 4 2 2021
pubmed: 5 2 2021
medline: 5 2 2021
Statut: epublish

Résumé

Human bone marrow-derived mesenchymal stem cells (hBMSCs) and their derivative enhanced green fluorescent protein (eGFP)-hBMSCs were employed to evaluate an innovative hybrid scaffold composed of granular hydroxylapatite and collagen hemostat (Coll/HA). The cellular morphology/cytoskeleton organization and cell viability were investigated by immunohistochemistry (IHC) and AlamarBlue metabolic assay, respectively. The expression of osteopontin and osteocalcin proteins was analyzed by IHC and ELISA, whereas osteogenic genes were investigated by quantitative PCR (Q-PCR). Cell morphology of eGFP-hBMSCs was indistinguishable from that of parental hBMSCs. The cytoskeleton architecture of hBMSCs grown on the scaffold appeared to be well organized, whereas its integrity remained uninfluenced by the scaffold during the time course. Metabolic activity measured in hBMSCs grown on a biomaterial was increased during the experiments, up to day 21 (

Identifiants

pubmed: 33537303
doi: 10.3389/fcell.2020.610570
pmc: PMC7849836
doi:

Types de publication

Journal Article

Langues

eng

Pagination

610570

Informations de copyright

Copyright © 2021 Mazzoni, Mazziotta, Iaquinta, Lanzillotti, Fortini, D’Agostino, Trevisiol, Nocini, Barbanti-Brodano, Mescola, Alessandrini, Tognon and Martini.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Crit Rev Oral Biol Med. 2000;11(3):279-303
pubmed: 11021631
J Cell Biochem. 2007 Oct 15;102(3):759-68
pubmed: 17516513
Sci Rep. 2018 May 31;8(1):8475
pubmed: 29855498
Stem Cell Res Ther. 2017 Feb 7;8(1):29
pubmed: 28173835
Regen Ther. 2019 Apr 22;12:2-5
pubmed: 31890760
Mater Today Bio. 2019 May 31;3:100009
pubmed: 32159148
Clin Orthop Relat Res. 2004 Oct;(427 Suppl):S123-8
pubmed: 15480054
Nature. 2014 Mar 20;507(7492):376-380
pubmed: 24647000
Prog Mol Biol Transl Sci. 2017;148:203-303
pubmed: 28662823
Front Cell Dev Biol. 2019 Nov 12;7:268
pubmed: 31799249
Sci Transl Med. 2020 Feb 5;12(529):
pubmed: 32024800
J Oral Maxillofac Surg. 2016 Jun;74(6):1238.e1-1238.e15
pubmed: 26954559
J Cell Physiol. 2013 Jun;228(6):1229-37
pubmed: 23129455
FASEB J. 2017 Oct;31(10):4555-4565
pubmed: 28659417
Neuro Oncol. 2014 Apr;16(4):513-9
pubmed: 24305701
Cells. 2019 Jul 28;8(8):
pubmed: 31357692
Mol Med Rep. 2019 May;19(5):3807-3814
pubmed: 30896834
Semin Cell Dev Biol. 2018 Jan;73:177-187
pubmed: 28830743
Mol Med Rep. 2017 Dec;16(6):8455-8462
pubmed: 28983617
Trends Cell Biol. 2004 Feb;14(2):86-93
pubmed: 15102440
Int J Mol Sci. 2019 Oct 09;20(20):
pubmed: 31600954
J Biomed Mater Res B Appl Biomater. 2018 Jul;106(5):2046-2057
pubmed: 28650094
Life Sci. 2020 Mar 15;245:117389
pubmed: 32007573
Endocrinology. 2019 Mar 1;160(3):675-683
pubmed: 30715256
Int J Mol Sci. 2019 Jan 31;20(3):
pubmed: 30709008
Methods Cell Biol. 2007;83:347-72
pubmed: 17613316
Cancer. 2015 Mar 1;121(5):708-15
pubmed: 25377935
Int J Mol Sci. 2018 Jul 25;19(8):
pubmed: 30044394
J Mech Behav Biomed Mater. 2015 Dec;52:22-50
pubmed: 26144973
Drug Deliv. 2018 Nov;25(1):750-756
pubmed: 29516759
Biomater Res. 2019 Oct 17;23:15
pubmed: 31641529
Stem Cells Transl Med. 2020 Mar;9(3):377-388
pubmed: 31834992
Pathol Oncol Res. 2020 Jul;26(3):1677-1685
pubmed: 31598896
Int J Mol Sci. 2018 Nov 14;19(11):
pubmed: 30441872
J Orthop Res. 2019 Jun;37(6):1229-1235
pubmed: 31081558
Osteoarthritis Cartilage. 2020 Mar;28(3):334-343
pubmed: 31958497
Stem Cell Res Ther. 2019 Nov 21;10(1):340
pubmed: 31753036
J Mol Histol. 2019 Aug;50(4):389-404
pubmed: 31214852
J Mol Cell Cardiol. 2008 Aug;45(2):270-80
pubmed: 18597775
Int J Mol Med. 2019 Feb;43(2):1085-1093
pubmed: 30483761

Auteurs

Elisa Mazzoni (E)

Department of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.

Chiara Mazziotta (C)

Department of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.

Maria Rosa Iaquinta (MR)

Department of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.

Carmen Lanzillotti (C)

Department of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.

Francesca Fortini (F)

Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.

Antonio D'Agostino (A)

Department of Surgical Odonto-Stomatological Sciences, University of Verona, Verona, Italy.

Lorenzo Trevisiol (L)

Department of Surgical Odonto-Stomatological Sciences, University of Verona, Verona, Italy.

Riccardo Nocini (R)

Department of Surgical Odonto-Stomatological Sciences, University of Verona, Verona, Italy.

Giovanni Barbanti-Brodano (G)

Department of Oncologic and Degenerative Spine Surgery, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Andrea Mescola (A)

CNR-Nanoscience Institute-S3, Modena, Italy.

Andrea Alessandrini (A)

CNR-Nanoscience Institute-S3, Modena, Italy.
Department of Physics, Informatics and Mathematics, University of Modena and Reggio Emilia, Modena, Italy.

Mauro Tognon (M)

Department of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.

Fernanda Martini (F)

Department of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.

Classifications MeSH